AUSTIN, Texas, March 20, 2017 (GLOBE NEWSWIRE) — Pain Therapeutics, Inc. (Nasdaq:PTIE) today announced positive regulatory guidance from a recent meeting with the U.S. Food and Drug Administration (FDA) regarding REMOXY (extended-release oxycodone capsules CII), its lead drug candidate. The Company will host a conference call tomorrow morning at 8am EDT to discuss REMOXY, and ...
The post Pain Therapeutics Announces Positive Regulatory Guidance for REMOXY™ ER appeared first on ForexTV.
March 21, 2017 at 04:07AM
http://ift.tt/2mmJYnW
from Nasdaq NewsFeed
http://ift.tt/2mmJYnW
No comments:
Post a Comment